$NRSN Could be interesting play for 2025

Undervalued in my opinion… why?

• Patents locked till 2044 for their drug PrimeC

• First-ever ALS data showing a 58% increase in survival rates.

• Couple days ago CEO bought $5M worth of shares at $1.25

• Partnerships coming + Big Pharma very likely just around the corner for buyout.

• They’ve already submitted for approval in Canada, plan is to rollout drug in 2026

• Phase 2b completed, planning for Phase 3 is already received positive reactions from FDA

• On top of ALS, they’re working on Parkinson’s and Alzheimer’s, which is insane for a company with a current $25M market cap.

I’m buying dips until something big drops. There are also risks of course but I believe there’s a small chance phase 3 results won’t be positive. Opened a decent position at $1.28.